Last week we visited Haematology at Lincoln for consultation and yesterday for further bone marrow biopsy/aspiration, further X-rays and now we wait the results. On Monday 15th the Doctors will meet and consult with Prof Russell from the Clinical Haematology Centre Nottingham ( Hamada's Stem Cell Transplant Specialist) with the view to Hamada starting Velcade. We will then return on the 18th February for their collective thoughts. As I have mentioned here several times it is not an easy decision to arrive at. Hamada has enjoyed two years three months since his Stem Cell Transplant with no Chemotherapy, a quiet life but a reasonable one. Now with his M-Spike/Para Protein at a whopping 18.1!! a decision must be made, the higher this reading the more damage will be done to his already fragile bones and organs. His kidneys, which at one time were at 6% are now holding well at 15% but still another reason to be very cautious. Velcade is a newer chemotherapy drug that Hamada has not tried before and is allowed here on the NHS for first relapse. Velcade is widely used in America, some patients doing very well indeed but there are problems associated with it - neuropathy and anemia being just two and with Hamada's very poor blood counts could be the greatest risk. A balancing act indeed but as MM has powerfully reared it's ugly head again, we feel we must wage war once more.